Originalsprache | Englisch |
---|---|
Aufsatznummer | e14005 |
Fachzeitschrift | Pediatric Allergy and Immunology |
Jahrgang | 34 |
Ausgabenummer | 8 |
DOIs | |
Publikationsstatus | Veröffentlicht - Aug. 2023 |
ASJC Scopus Sachgebiete
- Pädiatrie, Perinatalogie und Gesundheitsvorsorge bei Kindern
- Immunologie und Allergologie
- Immunologie
Zugriff auf Dokument
Andere Dateien und Links
Dieses zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
in: Pediatric Allergy and Immunology, Jahrgang 34, Nr. 8, e14005, 08.2023.
Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Brief/kurzer Abriss
TY - JOUR
T1 - Association in molecular profiles of IgE sensitization to mugwort pollen allergens in Chinese parents and their offspring
AU - Zhao, Lan
AU - Chen, Jiongyi
AU - Wang, Yuqi
AU - Guo, Yirong
AU - Feng, Yan
AU - Wang, Xuefeng
AU - Liu, Meiling
AU - Wang, Xueyan
AU - Ma, Tingting
AU - Zhang, Huanping
AU - Chen, Xiaoxue
AU - Zhang, Xianqi
AU - Fu, Wanyi
AU - Liu, Yi
AU - Xu, Puyang
AU - Gao, Biyuan
AU - Wang, Deyun
AU - Akkerdaas, Jaap H.
AU - van Ree, Ronald
AU - Valenta, Rudolf
AU - Vrtala, Susanne
AU - Gao, Zhongshan
N1 - Funding Information: Z. Gao, Y. Liu, and Y. Feng received funds from The Ministry of Science and Technology of China (2019YFE0106600). Y. Guo and L. Zhao received funds from Hangzhou Aileji Biotech Ltd (2016R1 and 2022R1). T. Ma received funds from the Wu jieping Foundation China (320.6750.2022‐02‐29). H. Zhang received funds from the Wu jieping Foundation China (320.6750.2022‐02‐31). Susanne Vrtala received funds from the Austrian government (CN 14/2020). Rudolf Valenta has received research grants from Worg Pharmaceuticals, Hangzhou, China, HVD Biotech, Vienna, Austria, and Viravaxx AG, Vienna, Austria. He serves as a consultant for Viravaxx and Worg. Ronald van Ree reports consultancies for HAL Allergy BV, Citeq BV, Angany Inc., Reacta Healthcare Ltd., Mission MightyMe, and AB Enzymes; speaker's fees from HAL Allergy BV, ALK, and Thermo Fisher Scientific; stock options from Angany Inc. All other authors declare no conflict of interest. Funding Information: This study was carried out with financial support from the National Key R&D Program of China (2019YFE0106600), OeAD – Austrian Agency for International Cooperation in Education and Research (CN 14/2020), Danube Allergy Research Cluster, Country of Lower Austria, Hangzhou Aileji Biotech Company, Hangzhou, China (Contracts 2016R1and 2022R1) and the Wu jieping Medical Foundation (320.6750.2022-02-29, 320.6750.2022-02-31). Z. Gao, Y. Liu, and Y. Feng received funds from The Ministry of Science and Technology of China (2019YFE0106600). Y. Guo and L. Zhao received funds from Hangzhou Aileji Biotech Ltd (2016R1 and 2022R1). T. Ma received funds from the Wu jieping Foundation China (320.6750.2022-02-29). H. Zhang received funds from the Wu jieping Foundation China (320.6750.2022-02-31). Susanne Vrtala received funds from the Austrian government (CN 14/2020). Rudolf Valenta has received research grants from Worg Pharmaceuticals, Hangzhou, China, HVD Biotech, Vienna, Austria, and Viravaxx AG, Vienna, Austria. He serves as a consultant for Viravaxx and Worg. Ronald van Ree reports consultancies for HAL Allergy BV, Citeq BV, Angany Inc., Reacta Healthcare Ltd., Mission MightyMe, and AB Enzymes; speaker's fees from HAL Allergy BV, ALK, and Thermo Fisher Scientific; stock options from Angany Inc. All other authors declare no conflict of interest. Funding Information: This study was carried out with financial support from the National Key R&D Program of China (2019YFE0106600), OeAD – Austrian Agency for International Cooperation in Education and Research (CN 14/2020), Danube Allergy Research Cluster, Country of Lower Austria, Hangzhou Aileji Biotech Company, Hangzhou, China (Contracts 2016R1and 2022R1) and the Wu jieping Medical Foundation (320.6750.2022‐02‐29, 320.6750.2022‐02‐31).
PY - 2023/8
Y1 - 2023/8
KW - Humans
KW - Allergens
KW - East Asian People
KW - Artemisia
KW - Pollen
KW - Immunoglobulin E
UR - http://www.scopus.com/inward/record.url?scp=85167429453&partnerID=8YFLogxK
U2 - 10.1111/pai.14005
DO - 10.1111/pai.14005
M3 - Letter/short communication
C2 - 37622256
AN - SCOPUS:85167429453
SN - 0905-6157
VL - 34
JO - Pediatric Allergy and Immunology
JF - Pediatric Allergy and Immunology
IS - 8
M1 - e14005
ER -